Skip to main content
. Author manuscript; available in PMC: 2013 Aug 16.
Published in final edited form as: Eur J Clin Invest. 2010 Aug 19;40(10):903–910. doi: 10.1111/j.1365-2362.2010.02347.x

Figure 5 A.

Figure 5 A

IL-6 in the soluble fraction of the skeletal muscle was elevated in ESRD patients pre-HD (7.74±8.1 pg/ml) compared to controls (0.62±0.49 pg/ml) and increased further at end-HD (347.0±209.2 pg/ml).

† p<0.05 Pre-HD vs. Control; ‡ p<0.001 End-HD vs. Control and Pre-HD